2346 tsm for Sale
DS5 Customized Synthesis Peptides High Purity Research Peptide Powder Bulk Supply
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10ml x 5mg/ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TR60Tirzepatide Source Factory Supplies Peptide Raw Materials - Safe One-stop Supply & Delivery of Peptides
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
60mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TR50High-purity, high-quality freeze-dried powder, suitable for laboratory research, best-selling product.
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
50mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
ET10 Customized Synthesis Peptides High Purity Research Peptide Powder Bulk Supply
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10ml x 10mg/ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
GND2 Customized Synthesis Peptides High Purity Research Peptide Powder Bulk Supply
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10ml x 2mg/ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
Products You May Be Interested in
Factory Direct Supply GND2 Peptide Powder, Competitive Price & Fast Shipment
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10ml x 2mg/ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
Factory Direct Supply 10 AD Peptide Powder, Competitive Price & Fast Shipment
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10ml x 10mg/ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TR40high-quality products, available in stock in the warehouse, fast and safe delivery,99% high-purity, on-time shipment,
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
40mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TR30Stable Supplier TR30 High purity synthetic peptide powder, 99% purity, on-time global delivery
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
30mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TR20| Certified Block | 99% | | Powder Peptide | Shipped from Chinese Warehouse
-
CAS No.:
1415456-99-3
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
20mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
- Finding tsm for sale in large quantity of choices all on www.echemi.com. The suppliers of 2346 tsm on the search result are been verified by the accurate information of each one. Accurate information is the prerequisite of transaction. Buy tsm with 70000+ customers on ECHEMI and make orders now.
- The quality of tsm will be secured by ECHEMI. Partners on ECHEMI are all selected in certification, qualification or scale. We help buyers to get tsm with various requirement and regulations in global countries and regions. We can offer tailored service of tsm for our customers.
- tsm in reasonable and fair market price will be provided with better options and services. Services of tsm like trade data and market price and insight can be subscribed on ECHEMI. You can enjoy the chemical supply chain services on ECHEMI. We will help you purchase tsm and run fast your business.
- •Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
- •TSMC, Samsung, and SK Hynix Scramble for Electronic-Grade Hydrofluoric Acid as High-End Supply Tightens; Some Suppliers Raise Prices by 30% This Year
- •$2.43 Billion Deal: Olin Buys Huntsman
- •BASF, Covestro, Huntsman Raise MDI Prices in North America Amid Global Supply Crunch
- •Losses Persist, Yet Huntsman Raises Prices — A Quiet Turning Point in the MDI Cycle